Nanobiotix (NBTX) EV to EBITDA (2020 - 2026)
Nanobiotix (NBTX) EV to EBITDA (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to EBITDA |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-894.16 |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
-572,130.99 |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-184,152.65 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-61,616.51 |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-170,532.26 |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-316,672.68 |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
22.68 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-322.18 |
| 10 |
Nanobiotix |
57.94 Mn |
-3.46 Mn |
- |
0.28 |
| Date | Value |
|---|
| Jun 9, 2026 |
0.28 |
| Jun 8, 2026 |
0.12 |
| Jun 5, 2026 |
0.12 |
| Jun 4, 2026 |
-0.08 |
| Jun 3, 2026 |
0.16 |
| Jun 2, 2026 |
-0.02 |
| Jun 1, 2026 |
-179,981.29 |
| May 29, 2026 |
-183,989.09 |
| May 28, 2026 |
-184,034.62 |
| May 27, 2026 |
-184,444.51 |
| May 26, 2026 |
-185,810.80 |
| May 22, 2026 |
-186,767.20 |
| May 21, 2026 |
-182,121.82 |
| May 20, 2026 |
-196,650.07 |
| May 19, 2026 |
-210,085.28 |
| May 18, 2026 |
-225,706.57 |
| May 15, 2026 |
-234,541.92 |
| May 14, 2026 |
-247,794.96 |
| May 13, 2026 |
-237,001.25 |
| May 12, 2026 |
-219,694.88 |
